GSK plc ( GLAXF) - Stock Earnings
GLAXF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2026Q1 | 2.3 billion USD | 10.1 billion USD |
| 2026Q2 | 576.3 million USD | 11.1 billion USD |
| 2026Q3 | 2.0 billion USD | 11.5 billion USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
GLAXF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 6.3 billion USD | 38.6 billion USD |
| 2024 | 3.2 billion USD | 39.4 billion USD |
| 2025 | 7.7 billion USD | 43.9 billion USD |
| 2026 Est. | — | — |
GLAXF
Price: $23.40
Dividend Yield: 3.18%
Payout Ratio: 51.48%
Earnings Per Share: 1.42 USD
P/E Ratio: 16.04
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United Kingdom
Market Capitalization: 91.2 billion
Average Dividend Frequency: 8
Years Paying Dividends: 23
DGR3: 19.79%
DGR5: 8.56%
DGR10: 2.50%
DGR20: 7.16%